Actualités

Albemarle (ALB) closed at $156.69 in the latest trading session, marking a -2.28% move from the prior day.

BHP Group raises Jansen Stage 2 investment to $6.9B after a detailed review, with first production expected in late FY31.

EMN expands in dielectric fluids with Jarylec acquisition, adding assets from Arkema and strengthening its power grid applications portfolio.

MT teams up with AWS to bring AI and cloud tools to steelmaking and supply lower-carbon steel under a multi-year deal.

Albemarle has underperformed its industry peers recently, yet analysts remain moderately optimistic about the stock’s prospects.

Alamos Gold cuts its Q2 output view after Young-Davidson seismic events, downtime and lower grades, while Island Gold is expected to support H2'26 production.

Albemarle (ALB) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

NUE sees Q2 EPS rising sharply from Q1 and year-ago levels, with segment gains, pricing strength and shareholder returns in focus.

Steel Dynamics sees Q2 EPS rising sharply on stronger steel and aluminum profits, despite a write-down tied to moving a planned recycled slab center.

Albemarle (ALB) is back on investors’ radars after recent share price swings, with the stock now around $160.35. The move has sharpened focus on performance, valuation signals, and underlying fundamentals. See our latest analysis for Albemarle. Over the past year, Albemarle has offered a very strong 1 year total shareholder return of 173.60%, even though the 3 year total shareholder return declined 25.71% and the 5 year total shareholder return is a modest 2.53%. This suggests momentum has...

Today, June 18, 2026, investor sentiment surged as QuantumScape announced a new partnership with Honda on battery innovation.

FMC's rimisoxafen deal with Corteva aims to expand access to dual-mode herbicide technology for corn and soybean markets across the Americas.

Investing.com -- Investing.com - Citi upgraded Albemarle shares to Buy from High Risk on Thursday, pointing to underappreciated growth opportunities in the lithium market despite recent spot price weakness. The bank kept its $225 price target on the stock.

BASF and Wacoal debut a 3D fiber armrest concept for auto seats, extending Melooop tech beyond apparel with lightweight design goals.

DOW shares have surged 39% YTD, fueled by cost cuts, productivity gains and growth projects in cost-advantaged regions amid macro challenges.

CE partners with Siegwerk to expand bio-based ethyl acetate use in printing inks, advancing sustainable, low-carbon packaging solutions.

Fortuna Mining secures environmental approval for Senegal's Diamba Sud Gold Mine, clearing a key hurdle as the project advances toward feasibility completion.

The latest trading day saw Albemarle (ALB) settling at $166.11, representing a -1.65% change from its previous close.

WLK's Wilhelmshaven plant acquisition expands its European footprint and strengthens the global chlorovinyls manufacturing network.

Rio Tinto and China Baowu reach a low-carbon steelmaking milestone, proving Pilbara Blend ore works in industrial-scale direct reduction trials.

SSR Mining boosts shareholder returns with a $500M buyback and dividend reinstatement, backed by strong cash flow growth and liquidity.

Valmont Industries' rally is backed by Infrastructure margin gains, utility demand, backlog growth and raised fiscal 2026 guidance.

ALB cut $1.3B in debt, lowered interest costs and boosted flexibility as asset sales and strong liquidity support its balance-sheet reset.

RS sees healthy demand and higher pricing ahead as acquisitions and infrastructure-driven markets continue to support growth.

Albemarle, Dycom Industries and Murphy USA are highlighted as earnings-upgrade beneficiaries as markets watch the Fed, G7 summit and key central banks.

Here is how Albemarle (ALB) and CF Industries (CF) have performed compared to their sector so far this year.

The average brokerage recommendation (ABR) for Albemarle (ALB) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

BASFY's Tinosorb S wins FDA approval, bringing the first new UV filter to U.S. consumers in 27 years and broadening sun care options.

Investors may be wondering whether Albemarle's share price still offers value after a strong run, or if most of the easy gains are already behind it. The stock last closed at US$170.42, with a 9.6% gain over the past week, a decline of 15.2% over the past month, and returns of 18.4% year to date and 184.5% over the past year. Over longer periods, the 3 year and 5 year figures sit at a decline of 21.8% and a gain of 14.5% respectively. Recent market attention has been shaped by ongoing...

DuPont's U.S. healthcare manufacturing sites now run on renewable electricity, advancing climate goals and lowering emissions.